Literature DB >> 11234872

The clinical implications of gemcitabine radiosensitization.

T H Doyle, F Mornex, W G McKenna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11234872

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice.

Authors:  Shingo Matsumoto; Shun Kishimoto; Keita Saito; Yoichi Takakusagi; Jeeva P Munasinghe; Nallathamby Devasahayam; Charles P Hart; Robert J Gillies; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2018-05-23       Impact factor: 12.701

2.  Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy.

Authors:  Long Shan Li; Erik A Bey; Ying Dong; Jieru Meng; Biswanath Patra; Jingsheng Yan; Xian-Jin Xie; Rolf A Brekken; Carlton C Barnett; William G Bornmann; Jinming Gao; David A Boothman
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 13.801

3.  Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump.

Authors:  Linda Waldherr; Maria Seitanidou; Marie Jakešová; Verena Handl; Sophie Honeder; Marta Nowakowska; Tamara Tomin; Meysam Karami Rad; Tony Schmidt; Joachim Distl; Ruth Birner-Gruenberger; Gord von Campe; Ute Schäfer; Magnus Berggren; Beate Rinner; Martin Asslaber; Nassim Ghaffari-Tabrizi-Wizsy; Silke Patz; Daniel T Simon; Rainer Schindl
Journal:  Adv Mater Technol       Date:  2021-04-12

4.  The role of apoptotic cell death in the radiosensitising effect of gemcitabine.

Authors:  B Pauwels; J B Vermorken; A Wouters; J Ides; S Van Laere; H A J Lambrechts; G G O Pattyn; K Vermeulen; P Meijnders; F Lardon
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.